批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2021/12/20 |
SUPPL-19(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/09/01 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2021/05/06 |
SUPPL-17(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2018/12/13 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/08/09 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/09/22 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
UNKNOWN
|
|
|
2014/09/15 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/09/27 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:IRBESARTAN 剂型/给药途径:TABLET;ORAL 规格:75MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020757 |
001 |
NDA |
AVAPRO |
IRBESARTAN |
TABLET;ORAL |
75MG |
Discontinued |
Yes |
No |
AB |
1997/09/30
|
SANOFI AVENTIS US |
077159 |
001 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
75MG |
Prescription |
No |
No |
AB |
2012/03/30
|
TEVA PHARMS |
202910 |
001 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
75MG |
Prescription |
No |
No |
AB |
2012/09/27
|
HETERO LABS LTD V |
077466 |
001 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
75MG |
Prescription |
No |
No |
AB |
2012/09/27
|
SANDOZ |
079213 |
001 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
75MG |
Prescription |
No |
No |
AB |
2012/09/27
|
ZYDUS PHARMS USA INC |
203071 |
001 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
75MG |
Prescription |
No |
No |
AB |
2012/09/27
|
PRINSTON INC |
203081 |
001 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
75MG |
Prescription |
No |
No |
AB |
2012/09/27
|
AUROBINDO PHARMA LTD |
202254 |
001 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
75MG |
Prescription |
No |
No |
AB |
2012/10/03
|
MACLEODS PHARMS LTD |
091236 |
001 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
75MG |
Prescription |
No |
No |
AB |
2012/10/15
|
ALEMBIC PHARMS LTD |
201531 |
001 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
75MG |
Prescription |
No |
No |
AB |
2012/10/15
|
LUPIN LTD |
077205 |
001 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
75MG |
Prescription |
No |
No |
AB |
2012/11/14
|
CHARTWELL MOLECULAR |
203534 |
001 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
75MG |
Prescription |
No |
No |
AB |
2015/02/23
|
JUBILANT GENERICS |
204774 |
001 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
75MG |
Prescription |
No |
No |
AB |
2015/12/07
|
SCIEGEN PHARMS INC |
203020 |
001 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
75MG |
Prescription |
No |
No |
AB |
2015/12/07
|
UNICHEM |
206194 |
001 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
75MG |
Prescription |
No |
No |
AB |
2016/06/14
|
HISUN PHARM HANGZHOU |
204740 |
001 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
75MG |
Prescription |
No |
No |
AB |
2018/04/17
|
AMNEAL PHARMS |
211056 |
001 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
75MG |
Prescription |
No |
No |
AB |
2024/05/22
|
IPCA LABS LTD |
活性成分:IRBESARTAN 剂型/给药途径:TABLET;ORAL 规格:150MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020757 |
002 |
NDA |
AVAPRO |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
Yes |
No |
AB |
1997/09/30
|
SANOFI AVENTIS US |
077159 |
002 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2012/03/30
|
TEVA PHARMS |
202910 |
002 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
HETERO LABS LTD V |
077466 |
002 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
SANDOZ |
079213 |
002 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
ZYDUS PHARMS USA INC |
203071 |
002 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
PRINSTON INC |
203081 |
002 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2012/09/27
|
AUROBINDO PHARMA LTD |
202254 |
002 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2012/10/03
|
MACLEODS PHARMS LTD |
091236 |
002 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2012/10/15
|
ALEMBIC PHARMS LTD |
201531 |
002 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2012/10/15
|
LUPIN LTD |
077205 |
002 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2012/11/14
|
CHARTWELL MOLECULAR |
203534 |
002 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2015/02/23
|
JUBILANT GENERICS |
204774 |
002 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2015/12/07
|
SCIEGEN PHARMS INC |
203020 |
002 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2015/12/07
|
UNICHEM |
206194 |
002 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2016/06/14
|
HISUN PHARM HANGZHOU |
204740 |
002 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2018/04/17
|
AMNEAL PHARMS |
211056 |
002 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
150MG |
Prescription |
No |
No |
AB |
2024/05/22
|
IPCA LABS LTD |
活性成分:IRBESARTAN 剂型/给药途径:TABLET;ORAL 规格:300MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020757 |
003 |
NDA |
AVAPRO |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
Yes |
Yes |
AB |
1997/09/30
|
SANOFI AVENTIS US |
077159 |
003 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
No |
No |
AB |
2012/03/30
|
TEVA PHARMS |
202910 |
003 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
HETERO LABS LTD V |
077466 |
003 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
SANDOZ |
079213 |
003 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
ZYDUS PHARMS USA INC |
203071 |
003 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
PRINSTON INC |
203081 |
003 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
No |
No |
AB |
2012/09/27
|
AUROBINDO PHARMA LTD |
202254 |
003 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
No |
No |
AB |
2012/10/03
|
MACLEODS PHARMS LTD |
091236 |
003 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
No |
No |
AB |
2012/10/15
|
ALEMBIC PHARMS LTD |
201531 |
003 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
No |
No |
AB |
2012/10/15
|
LUPIN LTD |
077205 |
003 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
No |
No |
AB |
2012/11/14
|
CHARTWELL MOLECULAR |
203534 |
003 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
No |
No |
AB |
2015/02/23
|
JUBILANT GENERICS |
204774 |
003 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
No |
No |
AB |
2015/12/07
|
SCIEGEN PHARMS INC |
203020 |
003 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
No |
No |
AB |
2015/12/07
|
UNICHEM |
206194 |
003 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
No |
No |
AB |
2016/06/14
|
HISUN PHARM HANGZHOU |
204740 |
003 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
No |
No |
AB |
2018/04/17
|
AMNEAL PHARMS |
211056 |
003 |
ANDA |
IRBESARTAN |
IRBESARTAN |
TABLET;ORAL |
300MG |
Prescription |
No |
No |
AB |
2024/05/22
|
IPCA LABS LTD |